GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Total Long-Term Assets

Acticor Biotech (XPAR:ALACT) Total Long-Term Assets : €1.26 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Acticor Biotech's Total Long-Term Assets for the quarter that ended in Jun. 2023 was €1.26 Mil.

Acticor Biotech Total Long-Term Assets Historical Data

The historical data trend for Acticor Biotech's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Total Long-Term Assets Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Long-Term Assets
Get a 7-Day Free Trial 0.29 0.95 0.90 1.01 1.21

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only 0.85 1.01 1.09 1.21 1.26

Acticor Biotech Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Acticor Biotech Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Total Long-Term Assets
Comparable Companies
XPAR:ALCLS XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM XPAR:ALDVI XPAR:SIGHT XPAR:ALCOX XPAR:ALVAL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
7V7:Germany
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Website
https://www.acticor-biotech.com
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines